Q1 2025 Holdings
Filed 2025-05-15 | 81 holdings | $939.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $118.2M | 1,550,000 | 12.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $65.6M | 650,000 | 7.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $44.2M | 1,100,000 | 4.7% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $37.0M | 275,000 | 3.9% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $36.5M | 2,300,000 | 3.9% |
| Elevance Health Inc(ELV) | COM | 036752103 | $28.3M | 65,000 | 3.0% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $27.9M | 250,000 | 3.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $27.6M | 1,150,000 | 2.9% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $27.3M | 270,000 | 2.9% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $27.0M | 300,000 | 2.9% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $19.6M | 175,000 | 2.1% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $17.1M | 500,000 | 1.8% |
| Fresenius Medical Care AG(FMS) | SPONSORED ADR | 358029106 | $16.9M | 680,000 | 1.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $16.6M | 150,000 | 1.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $15.6M | 100,000 | 1.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $14.9M | 675,000 | 1.6% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $14.0M | 775,000 | 1.5% |
| CVS Health Corp(CVS) | COM | 126650100 | $13.6M | 200,000 | 1.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $13.5M | 50,000 | 1.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $13.3M | 1,250,000 | 1.4% |
| Arcellx Inc(ACLX)Call | COMMON STOCK | 03940C100 | $13.1M | 200,000 | 1.4% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $12.8M | 145,000 | 1.4% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $12.6M | 60,000 | 1.3% |
| Radnet Inc(RDNT) | COM | 750491102 | $12.4M | 250,000 | 1.3% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $12.1M | 150,000 | 1.3% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $10.8M | 60,000 | 1.2% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $10.4M | 65,000 | 1.1% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $10.3M | 200,000 | 1.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $9.4M | 35,000 | 1.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $9.1M | 125,000 | 1.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $8.8M | 250,000 | 0.9% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $8.1M | 12,000 | 0.9% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $7.8M | 200,000 | 0.8% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $7.7M | 500,000 | 0.8% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $7.6M | 1,050,000 | 0.8% |
| Pfizer Inc(PFE) | COM | 717081103 | $7.6M | 300,000 | 0.8% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $7.6M | 250,000 | 0.8% |
| Masimo Corp(MASI) | COM | 574795100 | $7.5M | 45,000 | 0.8% |
| Waters Corp(WAT) | COM | 941848103 | $7.4M | 20,000 | 0.8% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $7.3M | 115,000 | 0.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $6.8M | 100,000 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE)Put | COM | 98420N105 | $6.7M | 200,000 | 0.7% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $6.6M | 925,000 | 0.7% |
| Edgewise Therapeutics Inc(EWTX)Call | COM | 28036F105 | $6.6M | 300,000 | 0.7% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $6.1M | 100,000 | 0.6% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $6.1M | 600,000 | 0.6% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $6.0M | 1,400,000 | 0.6% |
| Avidity Biosciences Inc(RNA)Put | COM | 05370A108 | $5.9M | 200,000 | 0.6% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $5.3M | 30,000 | 0.6% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $5.1M | 150,000 | 0.5% |